Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
139.00
+1.00 (0.72%)
Jun 18, 2026, 1:30 PM CST
TPEX:6712 Market Cap
TPEX:6712 has a market cap or net worth of 14.15 billion as of June 18, 2026. Its market cap has increased by 4.18% in one year.
Market Cap
14.15B
Enterprise Value
13.01B
Revenue
1.03B
Ranking
n/a
PE Ratio
27.64
Stock Price
139.00
Market Cap Chart
Since October 26, 2018, TPEX:6712's market cap has increased from 5.10B to 14.15B, an increase of 177.58%. That is a compound annual growth rate of 14.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 14.15B | -1.53% |
| Dec 31, 2025 | 14.37B | 1.47% |
| Dec 31, 2024 | 14.16B | -1.25% |
| Dec 29, 2023 | 14.34B | -4.57% |
| Dec 30, 2022 | 15.02B | 15.46% |
| Dec 30, 2021 | 13.01B | 32.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 22.94B |
| Sunmax Biotechnology | 20.42B |
| CHO Pharma | 17.83B |
| Lumosa Therapeutics | 17.75B |
| TaiMed Biologics | 15.52B |
| Medigen Vaccine Biologics | 14.93B |
| EirGenix | 13.62B |
| Polaris Group | 11.35B |